US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
CSE
Noveris Health Sciences Inc (NVRS) 銘柄情報

Noveris Health Sciences Inc (NVRS)

1.65

0.06

( 3.77% )

更新日時： 02:43:27

Noveris Health Sciences Inc (NVRS) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

1.65

( 3.77% )

買値

1.61

売値

1.66

出来高

103,146

1.57 日の範囲 1.68

0.175 52 週間の範囲 3.00

時価総額

前日終値

1.59

始値

1.64

時刻

最終取引時間

02:43:27

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 126,425

発行済株式数

58,548,051

配当利回り

PER

4.43

1 株当たり利益 (EPS)

0.33

歳入

-

純利益

1.6M

Noveris Health Sciences Inc., a biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. The company has a partnership with A... Noveris Health Sciences Inc., a biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Noveris Health Sciences Inc. was formerly known as Mydecine Innovations Group Inc. and changed its name to Noveris Health Sciences Inc. in February 2026. The company was incorporated in 2013 and is headquartered in Vancouver, Canada. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

noveris.health

本社

Vancouver, Canada

設立

2026

Noveris Health Sciences Inc is listed in the Healthcare sector of the Canadian Securities Exchange with ticker NVRS. The last closing price for Noveris Health Sciences was $1.59. Over the last year, Noveris Health Sciences shares have traded in a share price range of $ 0.175 to $ 3.00.

Noveris Health Sciences currently has 58,548,051 shares in issue. The market capitalisation of Noveris Health Sciences is $96.60 million. Noveris Health Sciences has a price to earnings ratio (PE ratio) of 4.43.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.47	-22.1698113208	2.12	2.25	1.28	270413	1.5530281	CS
4	-0.46	-21.8009478673	2.11	3	1.28	192835	2.09555745	CS
12	-0.55	-25	2.2	3	0.8	99125	1.93062295	CS
26	1.475	842.857142857	0.175	3	0.175	66324	1.86429911	CS
52	1.475	842.857142857	0.175	3	0.175	66324	1.86429911	CS
156	1.475	842.857142857	0.175	3	0.175	66324	1.86429911	CS
260	1.475	842.857142857	0.175	3	0.175	66324	1.86429911	CS

NVRS - Frequently Asked Questions (FAQ)

What is the current Noveris Health Sciences Inc share price?

The current share price of Noveris Health Sciences Inc is $ 1.65

How many Noveris Health Sciences Inc shares are in issue?

Noveris Health Sciences Inc has 58,548,051 shares in issue

What is the market cap of Noveris Health Sciences Inc?

The market capitalisation of Noveris Health Sciences Inc is CAD 96.6M

What is the 1 year trading range for Noveris Health Sciences Inc share price?

Noveris Health Sciences Inc has traded in the range of $ 0.175 to $ 3.00 during the past year

What is the PE ratio of Noveris Health Sciences Inc?

The price to earnings ratio of Noveris Health Sciences Inc is 4.43

What is the registered address of Noveris Health Sciences Inc?

The registered address for Noveris Health Sciences Inc is 1075 West Georgia Street, Vancouver, British Columbia, V6E 3C9

What is the Noveris Health Sciences Inc website address?

The website address for Noveris Health Sciences Inc is noveris.health

Which industry sector does Noveris Health Sciences Inc operate in?

Noveris Health Sciences Inc operates in the Pharmaceuticals sector

Guido2

Is Rick back blowing his horn? What happened?

CatfishHunter

CatfishHunter 4分前

I’m hoping they announce the next day after notice of approval. Although if they should get notice July 1 or 2nd, I’m fine with them waiting until July 6 to announce. I think good chance FDA sends out notice be end of day this Friday given next week is short work week and reviewers likely leaving

Hitman970

Hitman970 4分前

Eli's Gone

Eli's Gone 4分前

Never saw this one before:

Pete Crow-Armstrong (PCA) was controversially ruled out at second base after attempting a steal during a walk. Because it was Ball 4, PCA was entitled to the base; however, after sliding into the bag, he briefly lost contact with it and was tagged

jcromeenes

jcromeenes 4分前

These random WTF are we up days just confuse me. We're waiting for THAT EVENT and typically drift lower then an out of nowhere bounce happens to give us hope. It's like there's manipulation. Never! LOL.

MrMontag

MrMontag 5分前

So you sold 97000 shares at a loss?

US Market News

US Market News 5分前

Club Offers for Travel Enthusiasts in the U.S.June 24, 2026 1:44 PM
PR Newswire (US) class="legendSpanClass"NEW YORK, class="legendSpanClass"June 24, 2026 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announ

US Market News

US Market News 5分前

Royce Micro-Cap Trust (NYSE: RMT) as of May 31, 2026June 24, 2026 1:46 PM
PR Newswire (US) class="legendSpanClass"NEW YORK, class="legendSpanClass"June 24, 2026 /PRNewswire/ -- Average weekly trading volume of ap

havnagoodtime

havnagoodtime 5分前

I believe it is Zilla Nation that got rudely awakened over the past several years. And whatever teeny weeny contracts are brought in by Optilan India, they are chump change compared to the operating expenses, continuing net losses, and piled up debt. By the way, I'm sure you're aware of Dennis's new

Overwatch

Overwatch 6分前

I'm not versed as you are and I may have wrongfully assumed they could do another RS on the OTC since its a different exchange...

Best

88TH MAN

88TH MAN 6分前

XERI: The price is down, an opportunity to Buy. BULLISH!!!

nowwhat2

nowwhat2 6分前

https://investorshub.advfn.com/uimage/uploads/2026/6/24/tbrmqBTC_JUNE_24_10Y_200_ZOOM.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/24/jwvjbBTC_JUNE_24_10Y_200_ZOOM_W_OHTL.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/24/pkw

trunkmonk

trunkmonk 7分前

Actually it’s a free fall. Algo is just doing nothing.
Broke the back of every long.

lakers17

lakers17 7分前

Big moment for crypto on FOX Business today:

Coinbase Chief Policy Officer Faryar Shirzad says the Bitcoin Clarity Act could be the biggest financial regulatory bill since Dodd-Frank.
Wall Street is adapting — banks want in on tokenization and digital assets.

T

WhiteOwl

WhiteOwl 8分前

Totally ridiculous and makes no sense. No Volume, just manipulation!

THE OLD OWL 🦉🦉🦉

sherman106

sherman106 8分前

Putz....... Can't believe the LOW price of NB....... Taking a shellacking at the moment........ All the metals are dropping...... And, I got friends into this stock. Not happy people.......

BBANBOB

BBANBOB 8分前

when was the last time ya saw RKT up 12% sure didn't hurt us AT ALL and with 2 hrs left we already have the 50 day moving avg beat

Chartmaster

Chartmaster 8分前

MU earnings tonight, if it's a beat then watch Thursday open higher then fade with stocks, top is in, the SPY 720 puts for Aug or Sept are a steal right now imo

Krombacher

Krombacher 8分前

I agree with you that YOU are screwed.

Longs are not.

Krombacher

biosectinvestor

biosectinvestor 8分前

Thank you, Sentiment!

jhdf51

Yes..the voting thing is important and I believe he will get what he wants in some form and then sign. Though I believe there will be some changes.

JHD

bigballz

bigballz 9分前

There are no shares left to reverse split and something has to give? With the CEO going on record to discuss his part in the $150 million dollar deal?

SDCRBS

SDCRBS 10分前

ARE YOU READY $$$

🚀 EMINENT PRESS RELEASE:
VeeMost Is Sitting on a Fully-Built Tech Stack — and the Fuse Is Lit
Most people on this board still don’t realize how close VeeMost is to flipping the switch on something that normally takes big tech companies years

BigBadWolf

BigBadWolf 10分前

https://www.youtube.com/watch?v=42rmUlDiQDI
https://investorshub.advfn.com/uimage/uploads/2011/12/7/omsfbbbg.jpg

Noveris Health Sciences

CrowdStrike xStock

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。